Edited by Matthias J. Reddehase.
Paul R. Wratil and Holger F. Rabenau contributed equally to this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
In resource-limited or point-of-care settings, rapid diagnostic tests (RDTs), that aim to simultaneously detect HIV antibodies and p24 capsid (p24CA) antigen with high sensitivity, can pose important alternatives to screen for early infections. We evaluated the performance of the antibody and antigen components of the old and novel version of the Determine™ HIV-1/2 Ag/Ab Combo RDTs in parallel to quantifications in a fourth-generation antigen/antibody immunoassay (4G-EIA), p24CA antigen immunoassay (p24CA-EIA), immunoblots, and nucleic acid quantification. We included plasma samples of acute, treatment-naïve HIV-1 infections (Fiebig stages I–VI, subtypes A1, B, C, F, CRF02_AG, CRF02_AE, URF) or chronic HIV-1 and HIV-2 infections. The tests’ antigen component was evaluated also for a panel of subtype B HIV-1 transmitted/founder (T/F) viruses, HIV-2 strains and HIV-2 primary isolates. Furthermore, we assessed the analytical sensitivity of the RDTs to detect p24CA using a highly purified HIV-1NL4-3 p24CA standard. We found that 77% of plasma samples from acutely infected, immunoblot-negative HIV-1 patients in Fiebig stages II–III were identified by the new RDT, while only 25% scored positive in the old RDT. Both RDTs reacted to all samples from chronically HIV-1-infected and acutely HIV-1-infected patients with positive immunoblots. All specimens from chronically infected HIV-2 patients scored positive in the new RDT. Of note, the sensitivity of the RDTs to detect recombinant p24CA from a subtype B virus ranged between 50 and 200 pg/mL, mirrored also by the detection of HIV-1 T/F viruses only at antigen concentrations tenfold higher than suggested by the manufacturer. The RTD failed to recognize any of the HIV-2 viruses tested. Our results indicate that the new version of the Determine™ HIV-1/2 Ag/Ab Combo displays an increased sensitivity to detect HIV-1 p24CA-positive, immunoblot-negative plasma samples compared to the precursor version. The sensitivity of 4G-EIA and p24CA-EIA to detect the major structural HIV antigen, and thus to diagnose acute infections prior to seroconversion, is still superior.
UNAIDS (2016) Global AIDS Update 2016. http://www.unaids.org/en/resources/documents/2016/Global-AIDS-update-2016. Accessed 15 Dec 2019
WHO (2016) Global Health Sector Strategy on HIV, 2016–2021. http://www.who.int/hiv/strategy2016-2021/ghss-hiv/en/. Accessed 15 Dec 2019
Chu C, Selwyn PA (2010) Diagnosis and initial management of acute HIV infection. Am Fam Physician. 81:1239–1244 PubMed
Sáez-Cirión A, Bacchus C, Hocqueloux L, Avettand-Fenoel V, Girault I, Lecuroux C et al (2013) Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI study. PLoS Pathog 9:e1003211 PubMedPubMedCentralCrossRef
CDC (2014) National HIV testing day and new testing recommendations. Morb Mortal Wkly Rep 63:537
WHO (2015) Consolidated guidelines on HIV testing services. ISBN 978 92 4 150892 6. http://who.int/hiv/pub/guidelines/hiv-testing-services/en/. Accessed 15 Dec 2019
Wesolowski LG, Nasrullah M, Coombs RW, Rosenberg E, Ethridge SF, Hutchinson AB et al (2016) Acute infections, cost per infection and turnaround time in three united states hospital laboratories using fourth-generation antigen-antibody human immunodeficiency virus immunoassays. Open Forum Infect Dis 3:ofv188 PubMedCrossRefPubMedCentral
Ottiger CHR (2015) Comparison of the New Alere HIV Combe with Alere Determine HIV 1/2 Combo in acute primo and established HIV infections. Ann Clin Lab Res 3:22 CrossRef
Ochsenbauer C, Edmonds TG, Ding H, Keele BF, Decker J, Salazar MG et al (2012) Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J Virol 86:2715–2728 PubMedPubMedCentralCrossRef
Alere Medical Co. (2016) Determine™ HIV-1/2 Combo Package insert
Däumer M, Kaiser R (2003) Genotypische Resistenztestung. Oette, Kaiser, Häusinger: Resistenz in der HIV Therapie—Diagnostik und Management (ISSN: 3-89599-736-6)
ECBS Report Reference: WHO/BS/2018.2334 (2018) Geneva
- Comparative multi-assay evaluation of Determine™ HIV-1/2 Ag/Ab Combo rapid diagnostic tests in acute and chronic HIV infection
Paul R. Wratil
Holger F. Rabenau
Oliver T. Keppler
- Springer Berlin Heidelberg
Medical Microbiology and Immunology
Print ISSN: 0300-8584
Elektronische ISSN: 1432-1831
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II